Globus Medical Announces International Expansion
Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Kessler Foundation Research Center Presented Two Studies on Post-stroke Spatial Neglect at American Academy of Neurology
Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology
Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting
Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip
iMedica and Doctors' Administrative Solutions Partner to Accelerate Electronic Health Record Adoption
Caliper Life Sciences Reports First Quarter 2009 Results
Osteotech Reports First Quarter 2009 Financial Results
Thoratec Schedules First Quarter Conference Call, Webcast
'Best CRO' Award Recognizes Accelovance's Support of Vaccine Development
Medarex to Host Business and Financial Update Conference Call on Thursday, April 30, 2009
$89 Million Proposed Class Action Settlement Provides Consumers and Insurers With Money Back for Celebrex and Bextra Purchases and Reimbursements
For Alzheimer's Disease, Surveyed Neurologists Identify a Therapy's Effect on Cognitive Decline as the Attribute That Most Influences Their Prescribing Decisions
Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
ViroPharma Incorporated Reports First Quarter 2009 Financial Results
Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
Wyeth Reports Earnings Results for the 2009 First Quarter
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry
Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu
Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
New Treatment Discovered for Restless Legs Syndrome Improves Sleep
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.